









市场行情
/
股票
/
nasdaq-anik
/

Anika Therapeutics Inc

ANIK

9.540USD

-0.030-0.31%

交易中（美东）报价延迟15分钟

137.58M总市值

亏损市盈率 TTM



Anika Therapeutics Inc

9.540

-0.030-0.31%

概览公司财务分析

概览

公司

财务

分析

关于 Anika Therapeutics Inc 公司

Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.

Anika Therapeutics Inc简介



公司代码ANIK

公司名称Anika Therapeutics Inc

上市日期May 16, 1985

CEOBlanchard (Cheryl Renee)

员工数量288

证券类型Ordinary Share

年结日May 16

公司地址32 Wiggins Ave

城市BEDFORD

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编01730-2315

电话17814579000

网址https://anika.com/

公司代码ANIK

上市日期May 16, 1985

CEOBlanchard (Cheryl Renee)

Anika Therapeutics Inc公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Glenn R. Larsen, Ph.D.

Independent Director

50.26K

+39.24%

Ms. Sheryl L. Conley

Independent Director

39.84K

+55.16%

Mr. William R. (Bill) Jellison

Independent Director

23.10K

+158.45%

Mr. Joseph H. (Joe) Capper

Independent Director

20.40K

+227.02%

Mr. Stephen D. (Steve) Griffin

Chief Financial Officer, Chief Operating Officer, Executive Vice President

9.07K

Mr. Matt Hall

Director, Corporate Development and Investor Relations

Mr. Ian McLeod

Chief Accounting Officer, Vice President, Treasurer

Mr. Gary P. Fischetti

Independent Director

Dr. Cheryl Renee Blanchard, Ph.D.

President, Chief Executive Officer, Director

Mr. David B. Colleran, J.D.

Executive Vice President, General Counsel, Secretary

名称

名称/职务

职务

持股

持股变动

Dr. Glenn R. Larsen, Ph.D.

Independent Director

50.26K

+39.24%

Ms. Sheryl L. Conley

Independent Director

39.84K

+55.16%

Mr. William R. (Bill) Jellison

Independent Director

23.10K

+158.45%

Mr. Joseph H. (Joe) Capper

Independent Director

20.40K

+227.02%

Mr. Stephen D. (Steve) Griffin

Chief Financial Officer, Chief Operating Officer, Executive Vice President

9.07K

Mr. Matt Hall

Director, Corporate Development and Investor Relations

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

OEM Channel

16.34M

57.90%

Commercial Channel

11.88M

42.10%

地区USD

名称

营收

占比

United States

17.92M

63.52%

Other

5.54M

19.64%

Europe

4.75M

16.84%

业务

地区

业务USD

名称

营收

占比

OEM Channel

16.34M

57.90%

Commercial Channel

11.88M

42.10%

股东统计

更新时间: 12月4日周四

持股股东

股东类型

持股股东

占比

Trigran Investments, Inc.

11.24%

Caligan Partners, LP

9.95%

BlackRock Institutional Trust Company, N.A.

6.38%

The Vanguard Group, Inc.

5.41%

BlackRock Financial Management, Inc.

5.38%

其他

61.63%

持股股东

占比

Trigran Investments, Inc.

11.24%

Caligan Partners, LP

9.95%

BlackRock Institutional Trust Company, N.A.

6.38%

The Vanguard Group, Inc.

5.41%

BlackRock Financial Management, Inc.

5.38%

其他

61.63%

股东类型

持股股东

占比

Hedge Fund

29.85%

Investment Advisor/Hedge Fund

27.73%

Investment Advisor

25.43%

Individual Investor

4.88%

Research Firm

2.02%

Pension Fund

0.51%

Bank and Trust

0.12%

Venture Capital

0.09%

其他

9.38%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

245

12.37M

97.19%

-666.00

2025Q3

267

12.37M

100.32%

-461.27K

2025Q2

295

12.88M

103.23%

-71.30K

2025Q1

297

12.95M

103.38%

-1.70M

2024Q4

298

12.83M

102.20%

-560.99K

2024Q3

297

13.48M

104.72%

-150.44K

2024Q2

301

13.64M

105.78%

+30.78K

2024Q1

301

13.61M

105.08%

-1.78M

2023Q4

304

13.45M

105.34%

+303.47K

2023Q3

297

13.16M

105.14%

-356.42K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Trigran Investments, Inc.

2.04M

14.12%

-5.34K

-0.26%

Jun 30, 2025

Caligan Partners, LP

1.44M

9.95%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

937.30K

6.5%

-20.13K

-2.10%

Jun 30, 2025

The Vanguard Group, Inc.

779.47K

5.41%

+2.07K

+0.27%

Jun 30, 2025

BlackRock Financial Management, Inc.

546.12K

3.79%

+24.11K

+4.62%

Jun 30, 2025

Acadian Asset Management LLC

575.64K

3.99%

+36.03K

+6.68%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

623.08K

4.32%

+9.11K

+1.48%

Jun 30, 2025

The Capital Management Corporation

408.85K

2.84%

+79.19K

+24.02%

Jun 30, 2025

Boothbay Fund Management, LLC

529.50K

3.67%

Jun 30, 2025

Renaissance Technologies LLC

527.22K

3.66%

-1.40K

-0.26%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

Invesco NASDAQ Future Gen 200 ETF

0.56%

Royce Quant Small-Cap Quality Value ETF

0.2%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.1%

iShares Micro-Cap ETF

0.02%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.02%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.01%

Avantis US Small Cap Equity ETF

0.01%

Invesco RAFI US 1500 Small-Mid ETF

0.01%

WisdomTree US SmallCap Fund

0.01%

iShares Russell 2000 Value ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

占比0.56%

Royce Quant Small-Cap Quality Value ETF

占比0.2%

SPDR SSGA US Small Cap Low Volatility Index ETF

占比0.1%

iShares Micro-Cap ETF

占比0.02%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.02%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

占比0.01%

Avantis US Small Cap Equity ETF

占比0.01%

Invesco RAFI US 1500 Small-Mid ETF

占比0.01%

WisdomTree US SmallCap Fund

占比0.01%

iShares Russell 2000 Value ETF

占比0.01%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Anika Therapeutics Inc的前五大股东是谁？



Anika Therapeutics Inc 的前五大股东如下：
Trigran Investments, Inc.持有股份：2.04M，占总股份比例：14.12%。
Caligan Partners, LP持有股份：1.44M，占总股份比例：9.95%。
BlackRock Institutional Trust Company, N.A.持有股份：937.30K，占总股份比例：6.50%。
The Vanguard Group, Inc.持有股份：779.47K，占总股份比例：5.41%。
BlackRock Financial Management, Inc.持有股份：546.12K，占总股份比例：3.79%。